TITLE

Monotherapy versus Dual Therapy Based on Risk Categorization of Febrile Neutropenic Patients

AUTHOR(S)
Ohyashiki, K.
PUB. DATE
July 2004
SOURCE
Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS56
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cefepime monotherapy was compared with cefepime-plus-amikacin dual therapy for treatment of febrile neutropenic patients. Response rates were significantly lower for patients receiving monotherapy who had neutrophil counts of <500 cells/mm³ but did not differ significantly between patients receiving dual therapy who had neutrophil counts of ≥500 cells/mm³ or <500 cells/mm³. Dual therapy is recommended for the initial treatment of patients with neutropenia with <500 cells/mm³. Dual therapy was significantly more effective in patients with neutropenia lasting <5 days. The response rates to monotherapy or dual therapy did not differ significantly when neutropenia persisted for ≥6 days, indicating that sustained neutropenia is a risk factor for failure of initial empirical therapy. The rate of response to monotherapy was lower in leukemic patients, whereas the rate of response to dual therapy did not differ between leukemic and nonleukemic groups. The rate of response to either monotherapy or dual therapy did not differ for patients with temperatures of ≥38°C or 37.5°C-38°C. Overall, defervescence occurred in >80% of patients with mild infections, whereas only 32% of those with moderate to severe infection responded by day 3 and 69.8% by day 7.
ACCESSION #
13723713

 

Related Articles

  • Randomized Trial of Cefepime Monotherapy or Cefepime in Combination with Amikacin as Empirical Therapy for Febrile Neutropenia. Tamura, K.; Imajo, K.; Akiyama, N.; Suzuki, K.; Urabe, A.; Ohyashiki, K.; Tanimoto, M.; Masaoka, T. // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS15 

    A multicenter open randomized trial was conducted to compare cefepime monotherapy with cefepime/amikacin combination (dual) therapy in treating febrile neutropenic patients with hematologic disorders. Among the 189 evaluable patients, 5.8% had microbiologically and 10.6% had clinically...

  • COMPARISON OF ANTIBIOTICS; GRANULOCYTE COLONY-STIMULATING FACTOR IN CHILDREN WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA. Mahmood, Shahid; Tariq, Asma // Professional Medical Journal;2014, Vol. 21 Issue 4, p667 

    Objective: To determine if granulocyte colony-stimulating factor (G-CSF) with empirical antibiotics therapy accelerates febrile neutropenia resolution compared with antibiotics without it. Study design: Experimental study. Place and Duration of Study: Study was conducted for a period of one year...

  • Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study. DE CASTRO CARPEÑO, JAVIER; GASCÓN-VILAPLANA, PERE; CASAS-FERNÁNDEZ-DE TEJERINA, ANA MARIA; ANTÓN-TORRES, ANTONIO; LÓPEZ-LÓPEZ, RAFAEL; BARNADAS-MOLINS, AGUSTÍ; CRUZ-HERNÁNDEZ, JUAN JESÚS; MASSUTI-SUREDA, BARTOMEU; CAMPS-HERRERO, CARLOS; ARANDA-AGUILAR, ENRIQUE; REBOLLO LASERNA, FRANCISCO JOSÉ // Molecular & Clinical Oncology;2015, Vol. 3 Issue 3, p725 

    Febrile neutropenia (FN) is one of the most common adverse events associated with myelosuppressive chemotherapy for cancer treatment. The objective of this study was to describe the incidence of hospitalization due to FN in Spanish tertiary care hospitals (PINNACLE study). This epidemiological,...

  • Monotherapy versus Dual Therapy Based on Risk Categorization of Febrile Neutropenic Patients. Ohyashiki, K. // Clinical Infectious Diseases;7/15/2004 Supplement 1, Vol. 39, pS56 

    Cefepime monotherapy was compared with cefepime-plus-amikacin dual therapy for treatment of febrile neutropenic patients. Response rates were significantly lower for patients receiving monotherapy who had neutrophil counts of <500 cells/mm3 but did not differ significantly between patients...

  • Infections of Febrile Neutropenic Patients in Malignant Hematological Diseases (Second Study Period). Rókusz, László; Liptay, László // Military Medicine;Aug2005, Vol. 170 Issue 8, p653 

    Sixty-one febrile episodes among 27 neutropenic patients with malignant hematological diseases were studied during a study period between 1998 and 2001. The results were compared with the previous 3-year period. The main differences in treatment were that we did not use ciprofloxacin prophylaxis...

  • An Interesting Case of Primary Autoimmune Neutropenia. Doulgeraki, Artemis; Kotsonis, Kosmas; Lianou, Dimitra; Cassiou, Korina // Clinical Pediatrics;Apr2007, Vol. 46 Issue 3, p266 

    The article accounts on a clinical case of primary autoimmune neutropenia diagnosed in an 11-month-old girl. On examination, the infant who was in good condition and showing normal developmental milestones for her stage, had been febrile for a total of 21 days. She has a low absolute neutrophil...

  • FEBRIL NEUTROPENIA ETIOLOGY IN A HEMATOLOGY DEPARTMENT. Erikçi, Alev Akyol; Öztürk, Ahmet; Özyurt, Mustafa; Tekgündüz, AI Emre; Karagöz, Bülent; Bilgi, Oğuz; Bilekli, Fulya // European Journal of General Medicine;2008, Vol. 5 Issue 4, p228 

    Aim: Chemotherapy-induced febrile neutropenia (FN) predisposes patients to life-threatening infections and typically requires hospitalization. Patients with profound neutropenia have increased risk of septicemia associated with significant morbidity. To provide the appropriate broad-spectrum...

  • Neutrophilic Dermatoses. Cohen, Philip R. // American Journal of Clinical Dermatology;2009, Vol. 10 Issue 5, p301 

    Sweet syndrome, pyoderma gangrenosum, and subcorneal pustular dermatosis are neutrophilic dermatoses - conditions that have an inflammatory infiltrate consisting of mature polymorphonuclear leukocytes. The neutrophils are usually located within the dermis in Sweet syndrome and pyoderma...

  • Care of Patients With Neutropenia. Marrs, Joyce A. // Clinical Journal of Oncology Nursing;Apr2006, Vol. 10 Issue 2, p164 

    Presents information on neutropenia, a reduction in the white blood cell (WBC) count. Function of the WBC components; Causes; Diagnosis; Treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics